Skip to main content
SpringerLink
Log in

Nierenerkrankungen und Hypertonie in der Neurologie

  • Living reference work entry
  • First Online:
Klinische Neurologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 609 Accesses

Zusammenfassung

Die arterielle Hypertonie ist die häufigste internistische Erkrankung Deutschlands und wichtigster Risikofaktor für die Entstehung eines Schlaganfalls. Blutdruckhöhe und Dauer der Hypertonie korrelieren signifikant mit dem kardiovaskulären Risiko. Die arterielle Hypertonie steht in einem engen wechselseitigen Verhältnis mit der chronischen Nierenerkrankung (CKD). Entsprechend wächst der Anteil von CKD-Patienten in den westlichen Industrieländern kontinuierlich und liegt Schätzungen zufolge bei 10–15 %. Europaweit besteht die höchste Prävalenz der CKD in Nordostdeutschland (ca. 17 %). Neuere Erkenntnisse zur Prävalenz, Ätiologie und Bedeutung von Nieren- und Hochdruckerkrankungen und ihre Überschneidung mit zahlreichen neurologischen Krankheitsbildern geben Anlass zur Darstellung in diesem eigenständigen Kapitel. Neben der Thematik der akuten Nierenschädigung (AKI) und der CKD werden weitere Erkrankungen besprochen, die eine gemeinsame neurologische und nephrologische Betreuung erfordern. Wegen ihrer klinischen Relevanz wird auf die Problematik radiologischer Untersuchungen und Arzneimitteldosierungen bei Niereninsuffizienz eingegangen. Neu dargestellt wird der Einsatz der therapeutischen Apherese, mit der sich ein Feld der interdisziplinären Kooperation in der Therapie antikörperassoziierter neurologischer Erkrankungen etabliert hat.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • ACCORD Study Group (2010) Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med 362:1575–1585

    Article  Google Scholar 

  • Albanese A, Hindemarsh P, Stanhope R (2001) Management of hyponatriämie in patients with acute cerebral insults. Arch Dis Child 85:246–251

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alonso A, Lopez FL, Matsushita K et al (2011) Chronic kidney disease is associated with the incidence of atrial frillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123:2946–2953

    Article  PubMed  PubMed Central  Google Scholar 

  • Aymanns C, Keller F (2004) Arzneimitteldosierung bei Niereninsuffizienz – Fallstricke und Hilfen. Med Klin 99:613–624

    Article  Google Scholar 

  • Baumgaertel MW, Kraemer M, Berlit P (2014) Neurologic complications of acute and chronic renal disease. Handb Clin Neurol 119:383–393

    Article  PubMed  Google Scholar 

  • Chan KE, Lazarus JM, Thadhani R et al (2009) Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients with artrial fibrillation. J Am Soc Nephrol 20(4):872–881

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cooper CJ, Murphy TP, Cutlip DE et al (2014) CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 370:13–22

    Article  CAS  PubMed  Google Scholar 

  • Cowper SE, Robin HS, Steinberg SM et al (2000) Scleromyxoedema-like cutaneous disease in renal-dialysis patients. Lancet 356:1000

    Article  CAS  PubMed  Google Scholar 

  • Farres MT, Ronco P, Saadoun D et al (2003) Chronic lithium nephropathy: MR imaging for diagnosis. Radiology 229:570–574

    Article  PubMed  Google Scholar 

  • Fields LE (2004) The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44(4):398–404

    Article  CAS  PubMed  Google Scholar 

  • Fogari R, Preti P, Zoppi A et al (2007) Hypertension prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as screening test. Hypertens Res 30:111–117

    Article  PubMed  Google Scholar 

  • Frei U, Schober-Halstenberg H-H (2006) Nierenersatztherapie in Deutschland 2005–2006. Jahresbericht Quasi-Niere. Quasi-Niere, Berlin

    Google Scholar 

  • Gansevoort RT, Arici M, Benzing T et al (2016) Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrol Dial Transplant 31:337–348

    Article  PubMed  PubMed Central  Google Scholar 

  • GBD 2013: Mortality and Cause of Death Collaborators (2015) Global, regional, and national age–sex specific all-cause and cause- specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171

    Article  Google Scholar 

  • George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654–666

    Article  CAS  PubMed  Google Scholar 

  • Grobner T (2006) Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104

    Article  CAS  PubMed  Google Scholar 

  • Grünfeld JP, Rossier BC (2009) Lithium nephrotoxicity revisited. Nat Rev Nephrol 5(5):270–276

    Article  PubMed  Google Scholar 

  • Hoffmann B, Mayatepek E (2009) Morbus Fabry – oft gesehen, selten erkannt. Dtsch Arztebl Int 106(26):440–447

    PubMed  PubMed Central  Google Scholar 

  • Ibbeken C, Becker JU, Baumgärtel MW (2012) Nephrologische Nebenwirkungen einer Langzeittherapie mit Lithium. Dtsch Med Wochenschr 137:143–148

    Article  CAS  PubMed  Google Scholar 

  • Ibsen H, Olsen MH, Wachtell K et al (2005) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients. Hypertension 45:198–202

    Article  CAS  PubMed  Google Scholar 

  • Jamerson K, Weber MA, Bakris GL, ACCOMPLISH Trial Investigators et al (2008) Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359:2417–2428

    Article  CAS  PubMed  Google Scholar 

  • KDiGO 2012 Improving Global Outcomes (KDIGO) CKD Work Group (2013) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 3(Suppl 1):1–150

    Google Scholar 

  • Mancia G, Fagard R, Narkiewicz K et al (2013) ESH/ESC guidelines for the managment of arterial hypertension. J Hypertens 31:1281–1357

    Article  CAS  PubMed  Google Scholar 

  • McCullough PA, Wolyn R, Rocher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368–375

    Article  CAS  PubMed  Google Scholar 

  • Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network (AKIN): report of an initiative to improve outcome in acute kidney injury. Crit Care 11:R31

    Article  PubMed  PubMed Central  Google Scholar 

  • Metha R, Cai X, Lee J et al (2016) Association of fibroblast growth factor 23 with atrial fibrillation in chronic kidney disease, from the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol 5:548–556

    Google Scholar 

  • Nagal M, Hoshide S, Kario K (2010) Hypertension and dementia. Am J Hypertens 23:116–124

    Article  Google Scholar 

  • National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(Suppl 1):S1–S266

    Google Scholar 

  • Noël N, Maigné G, Tertian G, Anguel N, Monnet X, Michot JM, et al (2013) Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency. QJM 106(11):1017–1022

    Google Scholar 

  • Pereira AA, Weiner DE, Scott T et al (2005) Cognitive function in dialysis patients. Am J Kidney Dis 45:448–462

    Article  PubMed  Google Scholar 

  • Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264

    Article  PubMed  Google Scholar 

  • Ring T, Spiegelhalter D (2007) Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease. Kidney Int 72(11):1400–1402

    Article  CAS  PubMed  Google Scholar 

  • Schirpenbach C, Segmiller F, Diederich S et al (2009) The diagnosis and treatment of primary hyperaldosteronism in Germany – results on 555 patients from the German Conn Registry. Dtsch Arztebl Int 106(18):305–311

    PubMed  PubMed Central  Google Scholar 

  • Schwartz J, Winters JL, Padmanabhan A et al (2013) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 28:145–284

    Article  PubMed  Google Scholar 

  • Staessen JA, Gasowski J, Wang JG et al (2000) Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355:865–872

    Article  CAS  PubMed  Google Scholar 

  • Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369:1287–1301

    Article  PubMed  Google Scholar 

  • Van Berendoncks AM, Elseviers MM, Lins RL, for the SHARF Study Group (2010) Outcome of acute kidney injury with different treatment options: long-term follow-up. Clin J Am Soc Nephrol 5:1755–1762

    Article  PubMed  PubMed Central  Google Scholar 

  • Villeneuve PM, Clark EG, Sikora L et al (2016) Health-related quality-of-life among survivors of acute kidney injury in the intensive care unit: a systematic review. Intensive Care Med 42:137–146

    Article  PubMed  Google Scholar 

  • Williams BM, MacDonald T, Morant S et al (2015) Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet 386:2059–2068

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wolf-Maier K, Cooper R, Banegas J et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada and United States. JAMA 289:2363–2369

    Article  PubMed  Google Scholar 

  • Wright JT Jr, Williamson JD, Whelton PK et al (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103–2116

    Article  CAS  PubMed  Google Scholar 

  • Zeng WT, Sun XT, Tang K et al (2015) Risk of thromboembolic events in atrial fibrillation with chronic kidney disease. Stroke 46(1):157–163

    Article  CAS  PubMed  Google Scholar 

  • Zhang Z, Wu P, Zhang J et al (2016) The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: a meta-analysis. Pharmacol Res 105:74–83

    Article  CAS  PubMed  Google Scholar 

  • Zilberberg MD, Exuzides A, Spalding J et al (2008) Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin 24(6):1601–1608

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1. Medizinische Klinik, St. Franziskus-Hospital Münster, Münster, Deutschland

    Martin W. Baumgärtel

Authors
  1. Martin W. Baumgärtel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin W. Baumgärtel .

Editor information

Editors and Affiliations

  1. Essen, Germany

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Baumgärtel, M. (2018). Nierenerkrankungen und Hypertonie in der Neurologie. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_175-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-44768-0_175-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-44768-0

  • Online ISBN: 978-3-662-44768-0

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation